BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hanafy AS, Abd-Elsalam S. Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective. World J Gastroenterol 2020; 26(46): 7272-7286 [PMID: 33362383 DOI: 10.3748/wjg.v26.i46.7272]
URL: https://www.wjgnet.com/1007-9327/full/v26/i46/7272.htm
Number Citing Articles
1
Takumi Umemura, Kazuki Nishikawa, Yoshikazu Mutoh, Hajime Sasano, Koji Kozaki, Tetsuya Yamada, Toshihiko Ichihara. Usage experience of remdesivir for SARS-CoV-2 infection in a patient with chronic cirrhosis of Child–Pugh class CJournal of Antimicrobial Chemotherapy 2021; 76(7): 1947 doi: 10.1093/jac/dkab076
2
Gholam Reza Sivandzadeh, Hassan Askari, Ali Reza Safarpour, Fardad Ejtehadi, Ehsan Raeis-Abdollahi, Armaghan Vaez Lari, Mohammad Foad Abazari, Firoozeh Tarkesh, Kamran Bagheri Lankarani. COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challengesWorld Journal of Clinical Cases 2021; 9(22): 6178-6200 doi: 10.12998/wjcc.v9.i22.6178
3
M. Vitrone, F. Mele, E. Durante-Mangoni, R. Zampino. Drugs and liver injury: a not to be overlooked binomial in COVID-19Journal of Chemotherapy 2022; 34(4): 207 doi: 10.1080/1120009X.2021.1988203
4
Roya Mahdavi, Zahra Akbari Jonoush, Mehri Ghafourian, Seyed Esmaeil Khoshnam, Fereshteh Nezhad Dehbashi, Maryam Farzaneh. The Effect of Remdesivir as an anti-COVID-19 Drug on Chicken Hepatocyte Enzymes; an in vitro StudyIranian Journal of Medical Microbiology 2023; 17(3): 309 doi: 10.30699/ijmm.17.3.309
5
Gabriela Xavier Ortiz, Gabriele Lenhart, Matheus William Becker, Karin Hepp Schwambach, Cristiane Valle Tovo, Carine Raquel Blatt. Drug-induced liver injury and COVID-19: A review for clinical practiceWorld Journal of Hepatology 2021; 13(9): 1143-1153 doi: 10.4254/wjh.v13.i9.1143
6
Mohammed Hussien Ahmed, Hebat Allah Abdel Maksoud Ahmed, Nahla Abd el-Aziz Nosair, Asmaa Mbarak Hassan, Dalia ElSayed Sherief, Aya Mohammed Mahros. Fecal Calprotectin as a Predictor of COVID-19 SeverityJournal of Coloproctology 2021; 41(04): 361 doi: 10.1055/s-0041-1736646
7
Wen-Zheng Yuan, Tao Fu. Liver Dysfunction in COVID-19: From Onset to RecoverySeminars in Liver Disease 2022; 42(02): 151 doi: 10.1055/s-0042-1745871
8
Lekha Saha, Soumya Vij, Kajal Rawat. Liver injury induced by COVID 19 treatment – what do we know?World Journal of Gastroenterology 2022; 28(45): 6314-6327 doi: 10.3748/wjg.v28.i45.6314
9
Kimia Kardani, Azam Bolhassani, Mona Kardani, Elnaz Agi. Correlation of SARS-CoV-2 Infection with Hepatitis and Liver DisordersJournal of Medical Microbiology and Infectious Diseases 2021; 9(3): 122 doi: 10.52547/JoMMID.9.3.122
10
George D Panayiotakopoulos, Dimitrios T Papadimitriou. Rifampicin for COVID-19World Journal of Virology 2022; 11(2): 90-97 doi: 10.5501/wjv.v11.i2.90
11
Yingqian Wang, Min Shen, Yujia Li, Jiangjuan Shao, Feng Zhang, Mei Guo, Zili Zhang, Shizhong Zheng. COVID‐19‐associated liver injury: Adding fuel to the flameCell Biochemistry and Function 2023; 41(8): 1076 doi: 10.1002/cbf.3883
12
Faisal Inayat, Hassam Ali, Pratik Patel, Rubaid Dhillon, Arslan Afzal, Attiq Ur Rehman, Muhammad Sohaib Afzal, Laraib Zulfiqar, Gul Nawaz, Muhammad Hassan Naeem Goraya, Subanandhini Subramanium, Saurabh Agrawal, Sanjaya K Satapathy. Association between alcohol-associated cirrhosis and inpatient complications among COVID-19 patients: A propensity-matched analysis from the United StatesWorld Journal of Virology 2023; 12(4): 221-232 doi: 10.5501/wjv.v12.i4.221